{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T10:09:10Z","timestamp":1747822150012,"version":"3.37.3"},"reference-count":25,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,1]]},"DOI":"10.2337\/dci23-0025","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T19:02:01Z","timestamp":1695236521000},"page":"1747-1749","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":1,"title":["Personalizing Early-Stage Type 1 Diabetes in Children"],"prefix":"10.2337","volume":"46","author":[{"given":"Catarina","family":"Limbert","sequence":"first","affiliation":[{"name":"1Unit of Paediatric Endocrinology and Diabetes, Hospital Dona Estef\u00e2nia, Lisbon, Portugal"},{"name":"2Comprehensive Health Research Centre, NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thekla","family":"von dem Berge","sequence":"additional","affiliation":[{"name":"3Children\u2019s Hospital AUF DER BULT, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0773-6961","authenticated-orcid":false,"given":"Thomas","family":"Danne","sequence":"additional","affiliation":[{"name":"3Children\u2019s Hospital AUF DER BULT, Hannover, Germany"},{"name":"4Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"2023092019011499600_B1","doi-asserted-by":"crossref","first-page":"eabc8980","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci Transl Med"},{"key":"2023092019011499600_B2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jama.2023.2064","article-title":"Effect of verapamil on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: a randomized clinical trial","volume":"329","author":"Forlenza","year":"2023","journal-title":"JAMA"},{"key":"2023092019011499600_B3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/pedi.13410","article-title":"ISPAD clinical practice consensus guidelines 2022: stages of type 1 diabetes in children and adolescents","volume":"23","author":"Besser","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"2023092019011499600_B4","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2023092019011499600_B5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00125-022-05751-0","article-title":"Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies","volume":"66","author":"Karpen","year":"2023","journal-title":"Diabetologia"},{"key":"2023092019011499600_B6","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1210\/jc.2003-031887","article-title":"Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY)","volume":"89","author":"Barker","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2023092019011499600_B7","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00125-022-05780-9","article-title":"Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening","volume":"65","author":"Weiss","year":"2022","journal-title":"Diabetologia"},{"key":"2023092019011499600_B8","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2337\/dc22-1960","article-title":"Refining the definition of stage 1 type 1 diabetes: an ontology-driven analysis of the heterogeneity of multiple islet autoimmunity","volume":"46","author":"Frohnert","year":"2023","journal-title":"Diabetes Care"},{"key":"2023092019011499600_B9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cei\/uxac087","article-title":"The longitudinal loss of islet autoantibody responses from diagnosis of type 1 diabetes occurs progressively over follow-up and is determined by low autoantibody titres, early-onset, and genetic variants","volume":"210","author":"Williams","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"2023092019011499600_B10","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.2337\/dc20-2122","article-title":"An age-related exponential decline in the risk of multiple islet autoantibody seroconversion during childhood","volume":"44","author":"Bonifacio","year":"2021","journal-title":"Diabetes Care"},{"key":"2023092019011499600_B11","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2337\/dc20-1836","article-title":"Islet autoimmunity and HLA markers of presymptomatic and clinical type 1 diabetes: joint analyses of prospective cohort studies in Finland, Germany, Sweden, and the U.S","volume":"44","author":"Anand","year":"2021","journal-title":"Diabetes Care"},{"key":"2023092019011499600_B12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00125-015-3830-2","article-title":"The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes","volume":"59","author":"Bingley","year":"2016","journal-title":"Diabetologia"},{"key":"2023092019011499600_B13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/dc16-0181","article-title":"Reversion of \u03b2-cell autoimmunity changes risk of type 1 diabetes: TEDDY study","volume":"39","author":"Vehik","year":"2016","journal-title":"Diabetes Care"},{"key":"2023092019011499600_B14","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc21-2612","article-title":"Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: the TEDDY study","volume":"45","author":"Krischer","year":"2022","journal-title":"Diabetes Care"},{"key":"2023092019011499600_B15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jama.2019.21565","article-title":"Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany","volume":"323","author":"Ziegler","year":"2020","journal-title":"JAMA"},{"key":"2023092019011499600_B16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/pedi.12674","article-title":"Family adjustment to diabetes diagnosis in children: can participation in a study on type 1 diabetes genetic risk be helpful?","volume":"19","author":"Smith","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"2023092019011499600_B17","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/pedi.13448","article-title":"The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study","volume":"23","author":"Houben","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"2023092019011499600_B18","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.2337\/db22-0360","article-title":"Islet autoantibody levels differentiate progression trajectories in individuals with presymptomatic type 1 diabetes","volume":"71","author":"Kwon","year":"2022","journal-title":"Diabetes"},{"key":"2023092019011499600_B19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s13063-022-06259-z","article-title":"INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes","volume":"23","author":"Dunger","year":"2022","journal-title":"Trials"},{"key":"2023092019011499600_B20","doi-asserted-by":"crossref","first-page":"e053669","DOI":"10.1136\/bmjopen-2021-053669","article-title":"Study protocol: minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes","volume":"11","author":"Wilhelm-Benartzi","year":"2021","journal-title":"BMJ Open"},{"key":"2023092019011499600_B21","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.2337\/dc22-0308","article-title":"Innovative designs and logistical considerations for expedited clinical development of combination disease-modifying treatments for type 1 diabetes","volume":"45","author":"Anderson","year":"2022","journal-title":"Diabetes Care"},{"key":"2023092019011499600_B22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2023092019011499600_B23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2337\/dc22-1297","article-title":"CGM metrics identify dysglycemic states in participants from the TrialNet Pathway to Prevention study","volume":"46","author":"Wilson","year":"2023","journal-title":"Diabetes Care"},{"key":"2023092019011499600_B24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2337\/db19-0329","article-title":"Longitudinal pattern of first-phase insulin response is associated with genetic variants outside the class II HLA region in children with multiple autoantibodies","volume":"69","author":"Koskinen","year":"2020","journal-title":"Diabetes"},{"key":"2023092019011499600_B25","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1210\/clinem\/dgac740","article-title":"\u03b2-Cell function and insulin sensitivity in youth with early type 1 diabetes from a 2-h 7-sample OGTT","volume":"108","author":"Galderisi","year":"2023","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/46\/10\/1747\/734777\/dci230025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/46\/10\/1747\/734777\/dci230025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T19:02:11Z","timestamp":1695236531000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/46\/10\/1747\/153623\/Personalizing-Early-Stage-Type-1-Diabetes-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,9,20]]},"published-print":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci23-0025","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"type":"print","value":"0149-5992"},{"type":"electronic","value":"1935-5548"}],"subject":[],"published":{"date-parts":[[2023,9,20]]}}}